Our Team

The People Behind ABMIUM

Scientists, operators and advisors helping build a more transparent research-reagent marketplace.

Leadership
Veron Duberry
Founder & CEO
Founder

Veron Duberry

Founder & CEO

Veron Duberry leads ABMIUM's marketplace, sourcing, quality and commercial strategy for Research Use Only reagents. His background spans bioscience research, antimicrobial-resistance microbiology, supplier intelligence, sustainability and research operations, with a focus on improving reagent provenance, accessibility and research confidence.

John Oluwafemi Teibo, PhD
Co-Founder & CSO
Co-Founder

John Oluwafemi Teibo, PhD

Co-Founder & CSO

John Oluwafemi Teibo, PhD supports scientific strategy around reproducibility and validation in biomedical research. His research background includes biochemistry, cancer proteomics, translational oncology, precision prevention, phosphoproteomics and systems biology.

Board of Advisors
Nathan Gardner, PhD

Nathan Gardner, PhD

Board Advisor
Purdue University

Nathan Gardner is a synthetic-biology professional with experience in protein engineering, expression technologies, assay development, product commercialisation and quality management.

Cell-free expression systems and assay development
Fidel Peacock, PhD

Fidel Peacock, PhD

Board Advisor
University College London

Fidel Peacock is a research-operations and technical-leadership professional with higher-education experience spanning research support, compliance, safety, facilities, research infrastructure and sustainability.

Research infrastructure and sustainability
Prof. Winston Morgan

Prof. Winston Morgan

Board Advisor
University of East London

Professor Winston Morgan advises ABMIUM on toxicology, clinical biochemistry, research impact and inclusive scientific practice.

Toxicologyresearch impact and inclusive practice